← Open Payments lookup

MEGAN CAMACHO: Open Payments

NPI 1467163733 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,311 in 56 payments from 17 companies in 2025. Trend: 2023 $335 · 2024 $1,351 · 2025 $1,311

Food & beverage: $1,311
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.9$209
Otsuka America Pharmaceutical, Inc.7$176
AstraZeneca Pharmaceuticals LP6$140
Novartis Pharmaceuticals Corporation5$105
Travere Therapeutics, Inc.5$93
Boehringer Ingelheim Pharmaceuticals, Inc.4$88
GlaxoSmithKline, LLC.3$75
Ardelyx, Inc.2$56
KYOWA KIRIN, INC.2$54
Amgen Inc.3$52

Products named: TARPEYO, JYNARQUE, FARXIGA, Fabhalta, JARDIANCE, IBSRELA, CRYSVITA, SHINGRIX.

Industry payments across TX — which companies pay providers there.